Mar 21, 2017 at Cancer Therapy Advisor

Bursectomy Not Recommended as Standard Treatment for cT3/T4 Gastric Cancer

By : Cancer Therapy Advisor

Bursectomy can be safely performed without increasing the risk of morbidity or mortality among patients with cT3 or cT4 gastric cancer, though it is not recommended as a standard treatment in this setting, according to a study being presented at the ASCO 2017 Gastrointestinal Cancers Symposium.

Read More
Mar 15, 2017 at Science Daily

‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon

By : Science Daily

Heard of collateral lethality? It’s a therapeutic strategy that uses gene deletions with no direct role in the tumor progression. A recent study published in Science Daily shows how scientists  discovered that this process can be used in novel therapy approaches for gastric cancer.

Read More
Mar 15, 2017 at PLOS One

miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression

By : PLOS One

New Plos Onestudy shows miR-1296-5p may be a tumor suppressor of the miRNA molecule in gastric cancer as well as a clinical classification marker and therapeutic target for metastasis.

Read More
Mar 14, 2017 at UC Davis Comprehensive Cancer Center

Faulty DNA error correction genes set stage for familial gastric cancer

By : UC Davis Comprehensive Cancer Center

Published in the Gastroenterology Journal, UC Davis researchers have identified genetic variations that contribute to familial gastric cancer. Inherited mutations – which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types – impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care and new gastric cancer therapies.

Read More
Mar 14, 2017 at The Asahi Shimbun

Scientists find new check for recurrence risk of gastric cancer

By : The Asahi Shimbun

Researchers have developed a technique to identify patients who are more likely to suffer a recurrence of gastric cancer based on the degree of abnormal DNA methylation.

Read More
SHARE